Gregory K. Peters, Co-CEO of Netflix, has filed a report detailing multiple transactions involving the company's common stock. The filings, submitted on November 5, 2026, reveal a series of acquisitions that underscore Peters' significant stake in the streaming giant. This update is particularly relevant as Netflix navigates a competitive landscape in the video streaming industry.
Background
Peters Gregory K is associated with Netflix Inc, a leading player in the video streaming sector. The company operates under the SIC code for Services-Video Tape Rental. Netflix has been a pioneer in the streaming industry, continually adapting to changing consumer preferences and competitive pressures. The recent filing is part of a series of disclosures, including several other Form 4 filings made by Peters throughout 2026.
What the Filing Says
The SEC filing reveals that on November 3, 2026, Peters acquired a total of 14018, 25930, and 14440 shares of Netflix common stock through transactions classified as 'M' for acquisition. Following these transactions, Peters holds a total of 173800 shares. Additionally, the filing indicates that Peters received 25930 and 14440 restricted stock units (RSUs) on the same date, which are set to vest in the future.
Impact
This update may affect various stakeholders, including investors and analysts who monitor executive ownership as a sign of confidence in the company's future. Peters' significant shareholding may enhance investor confidence in Netflix's leadership and strategic direction. The competitive landscape in the video streaming industry, marked by rivals like Disney+ and Amazon Prime Video, makes such disclosures particularly pertinent.
What's Next
The filing does not say what happens next.
Read Next
Longeveron Inc. Updates Beneficial Ownership Status
Metallus Inc. director purchases 10,000 shares at $16.61
APEX Innovation Acquisition updates SEC filing on ownership
CEO Liu Shaoren Acquires 208,971 Shares in Apex Innovation
Apex Innovation CEO Shaoren Liu Acquires Additional Shares
Bambusa Therapeutics sees new ownership stakes in SEC filing





